Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Antibody Seroprevalence in Santa Clara County, California
Eran Bendavid, Bianca Mulaney, Neeraj Sood, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 529

Showing 1-25 of 529 citing articles:

Assay Techniques and Test Development for COVID-19 Diagnosis
Linda J. Carter, L. Garner, Jeffrey Smoot, et al.
ACS Central Science (2020) Vol. 6, Iss. 5, pp. 591-605
Open Access | Times Cited: 945
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
European Journal of Epidemiology (2020) Vol. 35, Iss. 12, pp. 1123-1138
Open Access | Times Cited: 804
Antibody tests for identification of current and past infection with SARS-CoV-2
Jonathan J Deeks, Jacqueline Dinnes, Yemisi Takwoingi, et al.
Cochrane library (2020) Vol. 2020, Iss. 6
Open Access | Times Cited: 720
Infection fatality rate of COVID-19 inferred from seroprevalence data
John P. A. Ioannidis
Bulletin of the World Health Organization (2020) Vol. 99, Iss. 1, pp. 19-33F
Open Access | Times Cited: 565
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates
Gideon Meyerowitz‐Katz, Lea Merone
International Journal of Infectious Diseases (2020) Vol. 101, pp. 138-148
Open Access | Times Cited: 544
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 523
Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays
Antonio La Marca, Martina Capuzzo, Tiziana Paglia, et al.
Reproductive BioMedicine Online (2020) Vol. 41, Iss. 3, pp. 483-499
Open Access | Times Cited: 397
The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape
Nicholas Fraser, Liam Brierley, G.K. Dey, et al.
PLoS Biology (2021) Vol. 19, Iss. 4, pp. e3000959-e3000959
Open Access | Times Cited: 388
Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape
Neeraja Ravi, Dana L. Cortade, Elaine Ng, et al.
Biosensors and Bioelectronics (2020) Vol. 165, pp. 112454-112454
Open Access | Times Cited: 377
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients
Johannes Korth, Benjamin Wilde, Sebastian Dolff, et al.
Journal of Clinical Virology (2020) Vol. 128, pp. 104437-104437
Open Access | Times Cited: 343
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
Tyler J. Ripperger, Jennifer L. Uhrlaub, Makiko Watanabe, et al.
Immunity (2020) Vol. 53, Iss. 5, pp. 925-933.e4
Open Access | Times Cited: 341
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis
Panagiotis Galanis, Irène Vraka, Despoina Fragkou, et al.
Journal of Hospital Infection (2020) Vol. 108, pp. 120-134
Open Access | Times Cited: 328
The Rate of Underascertainment of Novel Coronavirus (2019-nCoV) Infection: Estimation Using Japanese Passengers Data on Evacuation Flights
Hiroshi Nishiura, T. Kobayashi, Yichi Yang, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 2, pp. 419-419
Open Access | Times Cited: 327
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
Kristina L. Bajema, Ryan E. Wiegand, Kendra M. Cuffe, et al.
JAMA Internal Medicine (2020) Vol. 181, Iss. 4, pp. 450-450
Open Access | Times Cited: 308
Indonesia in the Time of Covid-19
Susan Olivia, John Gibson, Rus’an Nasrudin
Bulletin of Indonesian Economic Studies (2020) Vol. 56, Iss. 2, pp. 143-174
Closed Access | Times Cited: 301
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Shuchi Anand, Maria E. Montez‐Rath, Jialin Han, et al.
The Lancet (2020) Vol. 396, Iss. 10259, pp. 1335-1344
Open Access | Times Cited: 297
Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis
Panagiota I. Kontou, Georgia G. Braliou, Niki Dimou, et al.
Diagnostics (2020) Vol. 10, Iss. 5, pp. 319-319
Open Access | Times Cited: 280
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Eli S. Rosenberg, James M. Tesoriero, Elizabeth M. Rosenthal, et al.
Annals of Epidemiology (2020) Vol. 48, pp. 23-29.e4
Open Access | Times Cited: 268
Reply: “Vitamin D Supplementation in Influenza and COVID-19 Infections. Comment on: Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths Nutrients 2020, 12(4), 988”
William B. Grant, Carole A. Baggerly, Henry Lahore
Nutrients (2020) Vol. 12, Iss. 6, pp. 1620-1620
Open Access | Times Cited: 264
Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 239
Estimating and Simulating a SIRD Model of COVID-19 for Many Countries, States, and Cities
Jesús Fernández‐Villaverde, Charles I. Jones
(2020)
Open Access | Times Cited: 237
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P. A. Ioannidis
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 215
Asymptomatic Transmission During the Coronavirus Disease 2019 Pandemic and Implications for Public Health Strategies
Hanalise V. Huff, Avantika Singh
Clinical Infectious Diseases (2020) Vol. 71, Iss. 10, pp. 2752-2756
Open Access | Times Cited: 209
Clinical Performance of Two SARS-CoV-2 Serologic Assays
Mei San Tang, Karl Hock, Nicole M Logsdon, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 8, pp. 1055-1062
Open Access | Times Cited: 204
Review of analytical performance of COVID-19 detection methods
Basant Giri, Shishir Pandey, Retina Shrestha, et al.
Analytical and Bioanalytical Chemistry (2020) Vol. 413, Iss. 1, pp. 35-48
Open Access | Times Cited: 204
Page 1 - Next Page

Scroll to top